# Road Mapping * **Definition:** A strategic planning process used in healthcare and healthcare technology to outline the steps, resources, and timelines necessary to achieve specific goals or implement new initiatives, ensuring alignment with organizational objectives and stakeholder needs. * **Taxonomy:** CTO Topics / Road Mapping ## News * Selected news on the topic of **Road Mapping**, for healthcare technology leaders * 415 news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/30/2025 | [**Out-of-hospital cardiac arrest survival drops during COVID-19 with racial disparities**](https://www.news-medical.net/news/20250530/Out-of-hospital-cardiac-arrest-survival-drops-during-COVID-19-with-racial-disparities.aspx) | [[News Medical Net]] | | 5/30/2025 | [**The National Hispanic Health Foundation Begins a Bold New Chapter to Build a Sustainable Healthcare System for All**](https://www.prnewswire.com/news-releases/the-national-hispanic-health-foundation-begins-a-bold-new-chapter-to-build-a-sustainable-healthcare-system-for-all-302468983.html) | [[PR Newswire]] | | 5/29/2025 | [**Saudi Arabia RNA Therapeutics Market Research 2025 - Yahoo Finance**](https://finance.yahoo.com/news/saudi-arabia-rna-therapeutics-market-142600845.html) | [[Yahoo Finance]] | | 5/27/2025 | [**Proteomic test could diagnose thousands of rare genetic diseases - HealthLeaders Media**](https://www.healthleadersmedia.com/cmo/proteomic-test-could-diagnose-thousands-rare-genetic-diseases) | [[HealthLeaders Media]] | | 5/7/2025 | [**Long-read genome sequencing: Transforming genetic diagnostics for rare diseases**](https://medicalxpress.com/news/2025-05-genome-sequencing-genetic-diagnostics-rare.html) | [[MedicalXpress]] | | 4/30/2025 | [**Asembia 2025: How Specialty Pharmacies Are Evolving to Support Rare Conditions**](https://www.pharmexec.com/view/asembia-2025-specialty-pharmacies-evolving-support-rare-conditions) | [[PharmExec]] | | 4/28/2025 | [**How integrated real-world data helps identify and improve outcomes for rare disease patients**](https://www.biopharmadive.com/spons/how-integrated-real-world-data-helps-identify-and-improve-outcomes-for-rare/745490/) | [[BioPharma Dive]] | | 4/28/2025 | [**Asembia 2025: The Specialty Pharma Pipeline - Pharmaceutical Executive**](https://www.pharmexec.com/view/asembia-2025-specialty-pharma-pipeline) | [[PharmExec]] | | 4/25/2025 | [**TeleRare Health® Launches a Virtual Genomic Consult Service for Patients with Rare and ...**](https://www.prnewswire.com/news-releases/telerare-health-launches-a-virtual-genomic-consult-service-for-patients-with-rare-and-genetics-based-diseases-for-minnesotans-302437546.html) | [[PR Newswire]] | | 4/18/2025 | [**I don't know what I'm supposed to call my rare kidney disease - STAT News**](https://www.statnews.com/2025/04/18/rare-disease-name-kidney-ahus-cm-tma-hemolytic-uremic-syndrome/) | [[STAT]] | | 4/3/2025 | [**Lucid Software Acquires airfocus to Deepen Support for Product Teams with Enhanced ...**](https://www.prnewswire.com/news-releases/lucid-software-acquires-airfocus-to-deepen-support-for-product-teams-with-enhanced-product-management-and-roadmapping-capabilities-302419388.html) | [[PR Newswire]] | | 3/25/2025 | [**Central Lab Services Market worth US$8.18 billion by 2030 with 6.5AGR - MarketsandMarkets™**](https://www.globenewswire.com/news-release/2025/03/25/3048726/0/en/Central-Lab-Services-Market-worth-US-8-18-billion-by-2030-with-6-5-CAGR-MarketsandMarkets.html) | [[Globe Newswire]] | | 2/27/2025 | [**Global effort enhances clinical care for children with rare genetic diseases**](https://medicalxpress.com/news/2025-02-global-effort-clinical-children-rare.html) | [[MedicalXpress]] | | 2/27/2025 | [**Global partnerships transforming diagnosis and treatment for rare genetic diseases**](https://www.news-medical.net/news/20250227/Global-partnerships-transforming-diagnosis-and-treatment-for-rare-genetic-diseases.aspx) | [[News Medical Net]] | | 2/27/2025 | [**Annual inReach SOS report emphasizes the value of Garmin satellite communication devices**](https://www.prnewswire.com/news-releases/annual-inreach-sos-report-emphasizes-the-value-of-garmin-satellite-communication-devices-302387225.html) | [[PR Newswire]] | | 2/17/2025 | [**Personalized Medicine Market Size to Advance USD 1,264.67 Bn by 2034 - Yahoo Finance**](https://finance.yahoo.com/news/personalized-medicine-market-size-advance-160000918.html) | [[Yahoo Finance]] | | 1/30/2025 | [**Maximizing Therapeutic Success in Rare Diseases through Basket & Umbrella Trial Designs ...**](https://www.prweb.com/releases/maximizing-therapeutic-success-in-rare-diseases-through-basket--umbrella-trial-designs-upcoming-webinar-hosted-by-xtalks-302364208.html) | [[PRWeb]] | | 11/12/2024 | [**Data Integration Market to Grow by USD 10.94 Billion (2024-2028), Driven by ... - PR Newswire**](https://www.prnewswire.com/news-releases/data-integration-market-to-grow-by-usd-10-94-billion-2024-2028-driven-by-growing-demand-for-data-integration-ai-powered-report-explores-market-evolution---technavio-302302815.html) | [[PR Newswire]] | | 10/14/2024 | [**BDCM Broadcast Marketing Group, Inc.**](https://seekingalpha.com/symbol/BDCM) | [[Seeking Alpha]] | | 9/16/2024 | [**How to (not) fund the future - POLITICO**](https://www.politico.com/newsletters/digital-future-daily/2024/09/16/how-to-not-fund-the-future-00179381) | [[Politico]] | | 9/15/2024 | [**The White House launched a politically potent high-tech program this year. There's a reason you haven't heard of it.**](https://www.politico.com/news/2024/09/16/biden-tech-powerhouses-hubs-00179016) | [[Politico]] | | 8/15/2024 | [**MIT's AI Risk Database May Prompt Business Processes Changes - PYMNTS.com**](https://www.pymnts.com/artificial-intelligence-2/2024/mits-ai-risk-database-may-prompt-business-to-change-processes/) | [[PYMTScom]] | | 7/22/2024 | [**Readers Write: Why RCM is the Most Interesting Opportunity in Healthcare**](https://histalk2.com/2024/07/22/readers-write-why-rcm-is-the-most-interesting-opportunity-in-healthcare/) | [[HISTalk]] | | 6/25/2024 | [**Oracle Cloud Helps Health Insurers Reduce Data Complexity and IT Costs**](https://www.prnewswire.com/news-releases/oracle-cloud-helps-health-insurers-reduce-data-complexity-and-it-costs-302180649.html) | [[PR Newswire]] | | 5/28/2024 | [**Yes, Agile Can Work in Medtech**](https://medcitynews.com/2024/05/yes-agile-can-work-in-medtech/) | [[MedCity News]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **RoadMap Technologies**: A company specializing in AI predictive analytics and forecasting, serving major life sciences companies. - **Lucid Software**: A company enhancing product management and roadmapping capabilities through acquisitions. - **Mike Hill**: Managing director of Octane Capital Markets, emphasizes the importance of a clear regulatory roadmap for medtech startups. - **GeneDx**: A leading provider in rare disease diagnostics, focusing on genomic sequencing to accelerate diagnoses. - **TeleRare Health**: Provider of virtual genomic consults for diagnosing and treating rare genetic conditions. - **Pharmacy Quality Alliance (PQA)**: An organization that compiles perspectives from key stakeholders on quality medication use for rare diseases. - **Inovalon**: A cloud-based platform provider that integrates national-scale connectivity and advanced analytics for healthcare. - **AlphaRose Therapeutics**: Leader in next-generation Antisense Oligonucleotide Therapeutics, focusing on rare genetic diseases. - **Oracle**: A technology company that launched the Health Insurance Data Exchange Cloud Service to streamline data exchanges for healthcare insurers. - **Curant Health**: A healthcare organization that launched Curant Rare™, focusing on improving clinical health outcomes for patients with rare diseases. - **Demet Aybar**: CEO of US Lab Partners, focuses on enhancing digital laboratory capabilities through partnerships. - **Boston Scientific**: A medical device manufacturer that recently received FDA approval for its Farapulse pulsed field ablation system. - **International Precision Child Health Partnership (IPCHiP)**: A collaborative effort aimed at using genomic data to enhance patient care for children with rare genetic diseases. - **Girish Navani**: CEO of eClinicalWorks, committed to supporting community health centers in clinical data reporting. - **Alkeus Pharmaceuticals**: A company focused on developing therapies for serious eye diseases, including Stargardt disease. - **Zareh Zurabyan**: Head of eLabNext Americas, highlights the shared vision for supporting scientific teams in life sciences. ### Partnerships and Collaborations - **Unravel Biosciences and COMBINED Brain**: A collaboration to accelerate the identification of potential drug candidates for ultra-rare genetic neurological disorders. - **Quest Diagnostics and a Pharmaceutical Company**: Collaboration to address the challenges of diagnosing an ultra-rare cancer through data-driven strategies. - **eClinicalWorks and Fairfax Medical Facilities**: Collaborated to improve UDS submissions and patient compliance metrics. - **ODAIA and Veeva**: An expanded partnership integrating ODAIA's Engagement Intelligence product into Veeva CRM to enhance pharma sales teams' engagement with healthcare professionals. - **eLabNext and US Lab Partners**: Formed a preferred vendor partnership to enhance digital laboratory capabilities for life sciences companies. - **International Precision Child Health Partnership (IPCHiP)**: Collaboration to improve diagnosis and treatment of rare genetic diseases. - **Curant Health and Rare Pharmaceutical Companies**: Curant Rare™ aims to assist rare pharmaceutical companies in their commercialization efforts through specialized medication support services. - **BioNTech and CEPI**: A partnership to enhance mRNA vaccine manufacturing capabilities in Africa, committing up to USD 145 million. - **Trifecta Technologies and Stripe**: Partnership aimed at enhancing payment management for Salesforce users. ### Innovations, Trends, and Initiatives - **RoadMap TrailBlazer**: The latest version of RoadMap Technologies' forecasting software, introducing AI innovations for enhanced business forecasting. - **USG NSSCET Implementation Roadmap**: Released by the Biden-Harris administration, it outlines recommendations for implementing national standards in critical and emerging technologies. - **Health Insurance Data Exchange Cloud Service**: Oracle's new cloud-native solution that allows insurers to create custom data mapping and validation rules, improving data interoperability. - **Virtual Genomic Consults**: TeleRare Health's initiative to provide rapid diagnoses and tailored treatment options for rare genetic conditions. - **Ascendion's Pathfinder**: Utilized by clients to uncover cost savings and enhance business impact through GenAI-driven insights. - **abcDNA Technology**: AlphaRose's proprietary platform aimed at improving oligonucleotide therapeutics for neurogenetic diseases. - **AI Risk Repository**: Developed by MIT researchers, this database catalogs potential AI pitfalls to guide safer AI implementation in healthcare. - **Rapid Genome Sequencing**: Proven effective in diagnosing conditions like infantile epilepsy, highlighting the importance of genomic technologies in clinical settings. - **AI in Revenue Cycle Management**: The integration of AI technologies in RCM processes is trending, with discussions on its potential for automation and efficiency improvements. - **Gene-STEPS Project**: IPCHiP's project demonstrating rapid genome sequencing effectiveness in diagnosing infantile epilepsy. - **RNA-based Therapeutics Market Growth**: Projected to grow significantly, indicating a trend towards personalized medicine and tailored treatment approaches. - **Basket and Umbrella Trial Designs**: Innovative clinical trial designs discussed in webinars to enhance therapy development for rare diseases. - **Curant Rare™**: A new business unit focused on improving clinical health outcomes for patients with rare diseases through specialized medication support services. ### Challenges and Concerns - **Data Fragmentation**: Challenges in working with rare disease data due to incomplete data and lack of clear diagnostic codes. - **Integration of Rare Diseases into Public Health Strategies**: Research emphasizes the need for better integration of rare diseases into health planning, especially in pandemic responses. - **Human Oversight in AI**: Despite advancements in AI, human oversight remains crucial in RCM processes due to the complexity and variability of payment rules. - **Lengthy Diagnostic Processes**: Patients with rare diseases often face an average of 7.6 years for diagnosis, leading to emotional and financial strain. - **Regulatory Approval Delays**: The slow pace of regulatory approval in the medical device sector can delay patient access to new treatments, prompting manufacturers to seek faster development methods. - **Barriers to Medication Access**: Identified barriers include accessibility and affordability, which hinder quality medication use for patients with rare diseases. - **EHR Interoperability**: Despite advancements, clinicians face significant hurdles in data integration, leading to inefficiencies and clinician burnout. - **Regulatory Scrutiny**: AI systems categorized as 'high-risk' may face increased scrutiny and compliance costs, raising concerns for businesses. - **Limited Treatment Options**: Approximately 95% of rare diseases lack FDA-approved treatments, creating barriers to access. - **Healthcare Disparities Exposed by COVID-19**: The pandemic highlighted disparities in healthcare access, particularly for patients with rare diseases. - **Funding Challenges**: Venture financing for medical devices declined by 31% in 2023, indicating a challenging funding environment for startups. - **Underfunding of Rare Diseases**: Many rare diseases remain underfunded, with only about 600 orphan drugs approved by the FDA.